B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ: IART )

22.15 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 321
Open 22.15
Bid (Size) 19.48 (5)
Ask (Size) 25.62 (3)
Prev. Close 22.15
Today's Range 22.15 - 22.15
52wk Range 16.80 - 45.42
Shares Outstanding 84,579,542
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Meet the Only 3 S&P 500 Stocks That Are Beating Nvidia This Year
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Is Integra LifeSciences Stock Soaring On Monday?
Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline. 
Via Benzinga

Performance

YTD
-3.78%
-3.78%
1 Month
-9.15%
-9.15%
3 Month
+26.64%
+26.64%
6 Month
-23.57%
-23.57%
1 Year
-48.86%
-48.86%

More News

Read More
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Unveiling 10 Analyst Insights On Integra Lifesciences
Via Benzinga
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
Via Benzinga
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Via Benzinga
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
From KASKELA LAW LLC
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
Via Talk Markets
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
NASDAQ:IART is an undervalued gem with solid fundamentals.
Via Chartmill
8 Analysts Have This To Say About Integra Lifesciences
Via Benzinga
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Via Benzinga
Why Integra Lifesciences Stock Is Sinking Today
Via The Motley Fool
Topics Earnings
Exposures Financial
IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
The 3 Best Brain-Computer Interface Stocks to Buy Now
Via InvestorPlace
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
Via Chartmill
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
Via Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.